APLS — Apellis Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $5.25bn
- $5.30bn
- $1.00bn
Brief: Apellis To Receive Up To $300 Million From Royalty Purchase Agreement With SOBI
U.S. RESEARCH ROUNDUP-Axalta Coating, Gulfport Energy, Rockwell Automation
Apellis Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Apellis Pharmaceuticals Q1 Basic EPS USD -0.74
Apellis Pharmaceuticals Inc expected to post a loss of 35 cents a share - Earnings Preview
Brief: Apellis Announces Craig Wheeler To Join The Board Of Directors
U.S. RESEARCH ROUNDUP-American Electric Power, Block and Lenz Therapeutics
U.S. STOCKS ON THE MOVE-BridgeBio Pharma, NetApp, Talen Energy
U.S. STOCKS ON THE MOVE-Recursion Pharmaceuticals, DoubleVerify Holdings, Praxis Precision Medicines
Apellis Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary
U.S. STOCKS ON THE MOVE-SoundHound AI, Duolingo, Owens & Minor
Apellis rises after quarterly revenue beats estimates
Brief: Apellis Pharmaceuticals Q4 Basic EPS USD -0.29
Brief: Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. RESEARCH ROUNDUP- Apellis Pharmaceuticals, Energizer Holdings, Walmart
U.S. RESEARCH ROUNDUP-Apollo, Booking Holdings, Portillos
Apellis Pharmaceuticals Inc reports results for the quarter ended in September 30 - Earnings Summary
U.S. STOCKS ON THE MOVE-Crypto, Louisiana-Pacific, Broadridge